Anthem, Inc. (ANTM)
(Delayed Data from NYSE)
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
4 Reasons Why UnitedHealth (UNH) Stock Looks Attractive Now
by Zacks Equity Research
UnitedHealth Group Inc. (UNH) remains the leader in the health insurance industry by virtue of its vast scale and tremendously diversified operations.
Molina Hit by Public Exchanges, Failed Aetna-Humana Merger
by Zacks Equity Research
Molina Healthcare Inc. (MOH) continues to suffer from ongoing issues related to the Affordable Care Act's insurance Marketplace.
Humana Poised to Grow on Government Business, Strong Capital
by Zacks Equity Research
Humana, Inc. (HUM) stock has long been an investor favorite owing to its strong fundamentals.
Cigna Ties Up with DaVita Unit for New Healthcare Plans
by Zacks Equity Research
Cigna Corporation (CI) recently announced a definitive agreement with HealthCare Partners, a division of DaVita Inc. (DVA).
Cigna-Anthem Merger Conflict Continues with Countersuit
by Zacks Equity Research
Cigna (CI)-Anthem (ANTM) fight has reached a stage where the focus is on the breakup fee and damages rather than the sealing of the deal.
Cigna Wants Divorce from Anthem Deal, Sues for Nearly $15 Billion
by Madeleine Johnson
On the heels of Aetna's (AET) and Humana's (HUM) announcement, health insurance competitors Cigna (CI) and Anthem (ANTM) also announced that their merger deal is done-zo on Tuesday.
Aetna, Humana Call Off $34 Billion Courtship in Bad Start to Valentine's Day
by Madeleine Johnson
On Tuesday, health insurance giants Aetna (AET) and Humana (HUM) announced that they have called off their merger agreement after a federal court decision struck down the deal as anticompetitive.
Zacks Industry Outlook Highlights: Anthem, Cigna, Aetna, Humana and U.S. Healthcare Providers iShares ETF
by Zacks Equity Research
Zacks Industry Outlook Highlights: Anthem, Cigna, Aetna, Humana and U.S. Healthcare Providers iShares ETF
Anthem-Cigna Merger Receives a Blow from Federal Judge
by Zacks Equity Research
As anticipated, the merger between Anthem Inc. (ANTM) and Cigna Corp. (CI) saw the same fate as that of Aetna and Humana which was blocked last month.
Health Insurance Industry Outlook - February 2017
by Zacks Equity Research
The overall uncertain outlook for Obamacare and final regulatory shape of this space continues to be a headwind for the sector as a whole.
Anthem (ANTM) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Anthem Inc.'s (ANTM) fourth-quarter 2016 adjusted net income per share of $1.76 surpassed the Zacks Consensus Estimate of $1.59 by 10.7%.
Anthem (ANTM) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Anthem beats on earnings. Our consensus called for EPS of $1.59, and the company reported EPS of $1.76.
Is a Beat in the Cards for Allstate's (ALL) Q4 Earnings?
by Zacks Equity Research
We expect Allstate Corporation (ALL) to beat earnings expectations when it reports fourth-quarter and full-year 2016 results, on Feb 1,
Aetna (AET) Earnings Beat Estimates in Q4, Revenues Miss
by Zacks Equity Research
Aetna's (AET) earnings of $1.63 per share, surpassing the Zacks Consensus Estimate of $1.45 and improving 19% year over year.
Why Anthem Inc. (ANTM) Might Surprise This Earnings Season
by Zacks Equity Research
Anthem Inc. (ANTM) is seeing encouraging earnings estimate revision activity as of late and carries a favorable rank, positioning the company for a likely beat this season.
What's in Store for Metlife (MET) this Earnings Season?
by Zacks Equity Research
MetLife, Inc. (MET) is scheduled to report fourth-quarter and full-year 2016 results on Feb 1, after market close.
Lincoln National (LNC) Q4 Earnings: A Beat in the Cards?
by Zacks Equity Research
We expect Lincoln National Corp. (LNC) to beat earnings expectations when it reports fourth-quarter and full-year 2016 results, on Feb 1, after market close.
Teladoc (TDOC) to Report Q4 Earnings: What's in Store? (revised)
by Zacks Equity Research
Telehealth provider Teladoc Inc. (TDOC) has not confirmed the time/date for its December-quarter earnings release yet, but the report will likely be fairly soon, as they last reported quarterly results on October 27, 2016.
Why HCA Holdings (HCA) is Likely to Beat on Earnings in Q4
by Zacks Equity Research
We expect HCA Holdings Inc. (HCA) to beat earnings expectations when it reports fourth-quarter and full-year 2016 results, on Jan 31.
Will Aflac (AFL) Disappoint Investors this Earnings Season?
by Zacks Equity Research
Aflac Inc. (AFL) is scheduled to report fourth-quarter and full-year 2016 results on Jan 31 after the closing bell.
Anthem (ANTM) Q4 Earnings: A Beat in Store for the Stock?
by Zacks Equity Research
We expect Anthem Inc. (ANTM) to beat expectations when it reports fourth-quarter results on Feb 1 before the market opens.
Is Disappointment in Store for Aetna (AET) in Q4 Earnings?
by Zacks Equity Research
Aetna Inc. (AET) is scheduled to report fourth-quarter and full-year 2016 results on Jan 31 before the opening bell.
Teladoc (TDOC) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Telehealth provider, Teladoc Inc. (TDOC ) is scheduled to report fourth-quarter and full-year 2016 results on Jan 27.
Aetna's Merger with Humana Foiled by Regulators, Stock Down
by Zacks Equity Research
Federal authorities reviewing the proposed Aetna Inc. (AET) and Humana Inc. (HUM) mega merger have now blocked the deal.
Is Anthem a Good Choice for Value Investors Right Now?
by Zacks Equity Research
Value investing is easily one of the most popular ways to find great stocks in any market environment.